The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

Would it be flip of me to say, “A whole bunch of stuff?” It’s one of the main reasons I was attracted to the practice in the ...

Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were $0.75. Operator: Welcome to BioNTech’s Third Quarter 2025 ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

I know how destructive unchecked addiction can be. All the victims of the ongoing opioid crisis do, too. And this is about more than addiction — as when rare but real cases of myocarditis appeared in ...

"We cannot continue to let our government slash the budget at the expense of our health. Speak up to your elected officials." ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

The mRNA vaccines developed to fight COVID-19 during the pandemic "did have a very important impact in decreasing hospitalizations, severe pneumonia and death." ...

President Donald Trump’s physician, Dr. Sean P. Barbabella, announced that after conducting a battery of tests, he found that ...